How about a little something not COVID-19? Coffee is, far and away, one of our most popular beverages, with an estimated 400 billion cups poured annually in the U.S. Despite that figure, powered by Starbucks, McDonald's and other big brands, we aren't even in the Top 10 consuming countries. So while sipping that cup of java or mocha, let's take a look at the history of coffee.
Search results
What happens to the global economy if the medicine ends up harming those it is meant to cure?
Geofencing is a virtual fence in the real world. When combined with our homing beacon -- the smartphone that identifies us everywhere we go -- it becomes a tool with extraordinary powers, for good and evil. Several recent court cases, which likely have escaped your attention, may give you more than a moment's pause in this era of the coronavirus.
The West Coast is aflame; thousands are being evacuated. Before we jump to a conclusion of why, can research inform our thinking? Yes, especially for, "Communities that meet or intermingle with undeveloped wildland vegetation, creating zones known as the wildland-urban interface…."
Europe used to be the voice of reason in antibiotic discovery and development, but that is no longer the case. The European Medical Agency, Europe's equivalent of the FDA, is requiring so many clinical trials for antibiotics that it is no longer feasible for companies to market the drugs in the E.U. ACSH advisor Dr. David Shlaes (pictured) explains.
Dr. Paul Offit, Chief of Infectious Diseases and Director of the Vaccine Education Center at Children’s Hospital of Philadelphia, discusses COVID-19 vaccines with Eric Topol, MD, Editor-in-Chief of the website, Medscape. From safety to side effects, to how protective they might be.
Four stories: Phylogenetic analysis suggests that coronavirus arrived in the U.S. between late January and early February. The coronavirus has resulted in more than 1.2 million years of life lost (YLLs) in the U.S. The coronavirus isn't the only game in town. And some people who are most likely to be affected by coronavirus are also refusing to go to the hospital.
Pop quiz! Who's dumber? Those courting health risks at the Sturgis motorcycle rally or the authors of the "study" making the rounds on the thousands of infections they created? OK, it's a trick question, because both groups have some explaining to do.
It is difficult to overstate the potential damage that an ineffective or unsafe coronavirus vaccine could inflict on confidence in public health institutions. Conspiracy theories already abound and would multiply further.
It's time for the Centers for Disease Control and Prevention to withdraw this page to correct its many errors and distortions. A principal author of the 2016 CDC Guidelines on the prescription of opioids to adults with chronic pain is responsible for many of these errors. Richard Lawhern (pictured) addressed these mistakes in this open letter.
The beginner's mind, a video of Tesla production (can you see what is missing?), a video that will put a smile on your face and bring back the joy of opening a present when you were a tween, how will the rise in remote work change our lives, and finally, a question of expertise.
Are there geographical differences in the spread of COVID-19? Does a region's "culture" contribute to the pandemic or simply the population density? Good questions. Let's take a look.
Skin cancers are among the most common tumors; after all, we're all held together by our skin. The improvements in 3D-ultrasounds provide a one-step measurement of a suspicious area's size, depth, margins, and tumor aggression. More importantly, it identifies the tumor invisible to the eye, a critical factor in skin cancer recurrence.
The University of Oxford, in collaboration with British pharmaceutical firm AstraZeneca, has produced a leading coronavirus vaccine candidate. However, the Phase 3 clinical trial was paused because one patient is thought to have developed a serious adverse reaction. What could it be?
What happens when politics and science mix? Scary stuff. Dr. Henry Miller examines the considerable downside of releasing any COVID vaccine prior to the completion of Phase 3 trials. The founding director of the FDA's Office of Biotechnology, Dr. Miller argues that precise science, not the date of an election, is critical at this time.
I read a short article this week about the social history surrounding epidemics. Like much of history, it has eerie similarities to our current times. Is it a precautionary tale, or a random pattern we imbue with meaning as we try to connect the dots?
Everyone knows that the elderly and those with co-morbidities are at greater risk for hospitalization and death from COVID-19. But are all co-morbidities the same? Do some conditions result in more or perhaps fewer hospitalizations and deaths? Let's take a look.
“The extent to which SARS-CoV-2, the novel coronavirus that causes COVID-19, will circulate during the 2020–21 influenza season is unknown. However, it is anticipated that SARS-CoV-2 and influenza viruses will both be active in the United States during the upcoming 2020–21 influenza season.” - CDC 2021 Guidelines
Sometimes studies are full of bad data. Sometimes they are just based on stupid ideas. Here's one that manages to incorporate both flaws. Should elderly people with broken ribs be given Tylenol in pill form or IV for pain? Perhaps a salami sandwich is a better offering ... since this study is full of baloney.
A study that found basically no link between hair color or dye use and cancer predictably was sensationalized by the media anyway.
Attendees of last month's virtual AMR conference learned about advances in reimbursement programs in Europe for antibiotics. However, no one should believe that these baby steps represent significant progress in the effort to fix the antibiotic marketplace. ACSH advisor Dr. David Shlaes explains.
In July, the CDC released a preliminary report showing that opioid‐related overdose deaths increased 6.2 percent from December 2018 to December 2019. During that same period, deaths due to fentanyl and its analogs increased 15.8 percent. Seemingly in a state of denial, weeks later H.R. 7701 was introduced in Congress, effectively doubling down on clearly failed policies. ACSH advisor Dr. Jeff Singer (pictured) takes a closer look at this issue while examining the wayward thinking permeating the House.
A large study just found that there was little, or no, evidence of cancer linked to the use of hair dye. But one of the most common dyes, para-phenylenediamine, could be reasonably expected by a chemist to be carcinogenic because of the conditions used in the dying process. Even though it's not. Here's why.
Are vaccines going to be adequately tested for safety and efficacy if Phase 3 clinical trials are not completed? Does convalescent plasma work to treat COVID? Is the COVID death toll inflated? We attempt to clarify these controversies.
Here we go: Zombies, in this case, among ants .... What's that listless, unfocused feeling that the time of COVID has created within us? ... Abbott's new 15-minute COVID test explained ... And a book review points out that not telling the public the whole story has historical roots.
Pagination
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!